Raman spectroscopic analysis of atypical proliferative lesions of the breast

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6088, Issue , 2006, Pages

  Subramanian, K ^a,b   Kendall, C ^a   Stone, N ^a   Brown, J C ^b   McCarthy, K ^b   Bristol, J ^b   Chan, Y H ^b  

^a Biophotonics Research Group   (United Kingdom)

^b GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cytogenetic; Ductal carcinoma in situ; Hyperplasia; Immunohistochemistry; Invasive cancer; Linear discriminant analysis; Principal component analysis; Proliferation; Spectroscopy

Indexed keywords

CYTOGENETIC; DUCTAL CARCINOMA IN SITU; HYPERPLASIA; PROLIFERATION;

BIOCHEMISTRY; DISEASES; MAMMOGRAPHY; PATHOLOGY; RAMAN SPECTROSCOPY; SPECTROMETERS;

TUMORS;

EID: 33646194794     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.644553     Document Type: Conference Paper

References (20)

1. Nowell, P.C The clonal evolution of tumour cell populations. Science194, 23-28, (1976).
2. Fialkow P.J, Clonal origin of human tumours. Biochem. Biophys. Acta 458, 283-321, 1976.
3. Beckmann, M.W, Niedracher, D, Schnurch, H.G, Gusterson, B.A. & Bender H.G.1997 Multistep carcinogenesis of breast cancer and tumour heterogeneity.J.Mol.Med.75, 429-439
4. Ingvarsson S et al. The BRCA1 and BRCA2 proteins and tumor pathogenesis, Anticancer Res. 1999, JulAug, 19(4B):2853-61.
5. Hanahan D. Weinberg RA. The hallmarks of cancer. Cell. 2000 Jan 7; 100(1):57-70
6. Allred DC et al. Biomarkers in early breast neoplasia.J.Cell Biochem.Suppl. 17G: 1993
7. DuPont WD et al.Risk factors for breast cancer in women with proliferative breast disease. Engl.J.Med. 312; 146-151, 1985.
8. Tavassoli FA et al A comparisons of the results of long term follow up for atypical intraductal hyperplasia and indraductal hyperplasia of the breast. Cancer, 65:518-529, 1990.
9. London SJ et al. A prospective study of benign breast disease and the risk of breast cancer.JAMA, 267:941-944, 1992.
10. Buerger H et al, Correlation of morphometric and cytogenetic parameters of genetic instability with chromosomal alterations in insitu carcinomas of the breast. American Journal of clinical pathology, 2000, 114:854-859.
11. Buerger H et al. Comparative genomic hybridisation of ductal carcinoma in situ of the breast- evidence of multiple genetic pathways.
12. Vos CB et al.Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histological type.Br J Cancer 2000;81,1410-1418
13. Korsching E et al.Cytogenetic alterations and cytokeratin expression patterns in breast cancer integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.
14. Jones C et al.Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. Pathol.2003 Feb 199(2): 152-6
15. Frank CJ et al.Characterisation of human breast biopsy specimens with near infrared Raman spectroscopy. Anal Chem 1994; 66:319-326.
16. Redd, DCB, et al. Raman spectroscopic characterisation of human breast tissues: implications for breast cancer diagnosis, Applied spectroscopy, 47, 6,787-791, 1993
17. Manoharan Ret al.Histochemical analysis of biological tissues using Raman spectroscopy.Spectrochimica Acta Part A 1996; 215-249
18. Alfano RR, et al: Fluorescence Spectra from cancerous and normal human breast and lung tissues, IEEE Journal of quantum Electronics, 23, 1806-1811, 1987
19. M.Feld et al.Histochemical analysis of biological tissues using Raman spectroscopy. Molecular and Biomolecular Spectroscopy. Vol 52,(20,1996pp215-249
20. G Puppels et al.Characterisation of breast duct epithelia: a Raman spectroscopic study, Vib.Spec 32(2003) 67-74.